Earnings Feed
Start Free
Home/Insiders/Gilson Michelle
GM
SEC Insider//CIK 0001930862

Gilson Michelle

CIK 00019308622 companiesSAN JOSE, CA
SEC Profile

Transactions

50

Companies

2

Filings

6

CIK

0001930862

Recent Transactions

50 trades
  • Award
    Rani Therapeutics Holdings, Inc.$RANI

    Director Stock Option (Right to Buy)

    2026-08-03+247,200→ 247,200 total
  • Disposition to Issuer
    Arcellx, Inc.

    Performance-based Restricted Stock Unit

    2026-04-28−59,028→ 0 total
  • Disposition to Issuer
    Arcellx, Inc.

    Restricted Stock Unit

    2026-04-28−88,542→ 0 total
  • Disposition to Issuer
    Arcellx, Inc.

    Stock Option (right to buy)

    2026-04-28−32,500→ 0 total
  • Disposition to Issuer
    Arcellx, Inc.

    Stock Option (right to buy)

    2026-04-28−70,796→ 0 total
  • Disposition to Issuer
    Arcellx, Inc.

    Stock Option (right to buy)

    2026-04-28−94,596→ 0 total
  • Disposition to Issuer
    Arcellx, Inc.

    Restricted Stock Unit

    2026-04-28−20,496→ 0 total
  • Disposition to Issuer
    Arcellx, Inc.

    Restricted Stock Unit

    2026-04-28−61,590→ 0 total
  • Award
    Arcellx, Inc.

    Performance-based Restricted Stock Unit

    2026-04-28+59,028→ 59,028 total
  • Disposition from Tender
    Arcellx, Inc.

    Common Stock

    2026-04-28−67,048→ 0 total
  • Disposition from Tender
    Arcellx, Inc.

    Common Stock

    2026-04-28−5,000→ 0 total
  • Disposition to Issuer
    Arcellx, Inc.

    Stock Option (right to buy)

    2026-04-28−40,205→ 0 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-04-16$8.66/sh+2,110→ 67,048 total
  • Exercise/Conversion
    Arcellx, Inc.

    Stock Option (right to buy)

    2026-04-16−2,110→ 40,205 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-04-15$8.66/sh+36,000→ 64,938 total
  • Exercise/Conversion
    Arcellx, Inc.

    Stock Option (right to buy)

    2026-04-15−36,000→ 42,315 total
  • Gift
    Arcellx, Inc.

    Common Stock

    2026-03-17−5,000→ 28,938 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2026-02-25$113.82/sh−11,219→ 33,938 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2026-02-19$67.73/sh−2,879→ 50,662 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2026-02-19$69.38/sh−100→ 45,157 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2026-02-19$68.57/sh−5,405→ 45,257 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2026-02-17$69.21/sh−7,141→ 57,691 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2026-02-17$70.01/sh−4,150→ 53,541 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-01-06+20,530→ 64,832 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-01-06+20,530→ 64,832 total
  • Exercise/Conversion
    Arcellx, Inc.

    Restricted Stock Unit

    2026-01-06−20,530→ 61,590 total
  • Exercise/Conversion
    Arcellx, Inc.

    Restricted Stock Unit

    2026-01-03−15,340→ 0 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-01-03+15,340→ 44,302 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-01-03+15,340→ 44,302 total
  • Exercise/Conversion
    Arcellx, Inc.

    Restricted Stock Unit

    2026-01-02−20,496→ 20,496 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-01-02+20,496→ 28,962 total
  • Award
    Arcellx, Inc.

    Restricted Stock Unit

    2026-01-02+88,542→ 88,542 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2026-01-02+20,496→ 28,962 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-10-15$91.04/sh−5,364→ 8,466 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-10-06$86.22/sh−1,064→ 13,830 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-10-03$86.00/sh−4,882→ 14,894 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-05-27$64.38/sh−8,449→ 19,776 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-05-27$63.62/sh−3,786→ 28,225 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2025-05-23+22,429→ 32,011 total
  • Exercise/Conversion
    Arcellx, Inc.

    Restricted Stock Units

    2025-05-23−22,429→ 0 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-08$73.69/sh−3,997→ 9,582 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-07$77.06/sh−2,327→ 18,339 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-07$75.53/sh−4,760→ 13,579 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-07$75.23/sh−1,546→ 22,917 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-07$74.43/sh−3,128→ 24,463 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-07$76.64/sh−2,251→ 20,666 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-06$77.17/sh−5,621→ 27,591 total
  • Sale
    Arcellx, Inc.

    Common Stock

    2025-01-06$77.17/sh−5,102→ 28,230 total
  • Award
    Arcellx, Inc.

    Restricted Stock Unit

    2025-01-06+82,120→ 82,120 total
  • Exercise/Conversion
    Arcellx, Inc.

    Common Stock

    2025-01-03+15,339→ 38,834 total

Companies

2

Recent Filings

6

Address

C/O RANI THERAPEUTICS LLC 2051 RINGWOOD AVE.

SAN JOSE, CA, 95131

View on SEC.gov